Experimental infections with Mycoplasma agalactiae identify key factors involved in host-colonization

PLoS One. 2014 Apr 3;9(4):e93970. doi: 10.1371/journal.pone.0093970. eCollection 2014.

Abstract

Mechanisms underlying pathogenic processes in mycoplasma infections are poorly understood, mainly because of limited sequence similarities with classical, bacterial virulence factors. Recently, large-scale transposon mutagenesis in the ruminant pathogen Mycoplasma agalactiae identified the NIF locus, including nifS and nifU, as essential for mycoplasma growth in cell culture, while dispensable in axenic media. To evaluate the importance of this locus in vivo, the infectivity of two knock-out mutants was tested upon experimental infection in the natural host. In this model, the parental PG2 strain was able to establish a systemic infection in lactating ewes, colonizing various body sites such as lymph nodes and the mammary gland, even when inoculated at low doses. In these PG2-infected ewes, we observed over the course of infection (i) the development of a specific antibody response and (ii) dynamic changes in expression of M. agalactiae surface variable proteins (Vpma), with multiple Vpma profiles co-existing in the same animal. In contrast and despite a sensitive model, none of the knock-out mutants were able to survive and colonize the host. The extreme avirulent phenotype of the two mutants was further supported by the absence of an IgG response in inoculated animals. The exact role of the NIF locus remains to be elucidated but these data demonstrate that it plays a key role in the infectious process of M. agalactiae and most likely of other pathogenic mycoplasma species as many carry closely related homologs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism
  • Female
  • Genetic Loci
  • Host-Pathogen Interactions
  • Mutation
  • Mycoplasma Infections / microbiology
  • Mycoplasma Infections / veterinary*
  • Mycoplasma agalactiae / genetics*
  • Mycoplasma agalactiae / pathogenicity*
  • Mycoplasma agalactiae / physiology
  • Sheep / microbiology*
  • Sheep Diseases / microbiology*

Substances

  • Bacterial Proteins

Grants and funding

This work was supported by grants from INRA (Animal Health Division, AAP 2012) and ENVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.